| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,382 |
6,075 |
$347K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,623 |
4,157 |
$152K |
| 80305 |
|
2,675 |
2,310 |
$28K |
| 99000 |
|
4,067 |
3,525 |
$13K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
119 |
108 |
$12K |
| 94060 |
|
221 |
202 |
$10K |
| 90686 |
|
349 |
336 |
$4K |
| 94664 |
|
234 |
215 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
103 |
26 |
$2K |
| 82962 |
|
933 |
772 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
89 |
25 |
$2K |
| 0012A |
|
50 |
50 |
$1K |
| 0001A |
|
46 |
46 |
$1K |
| 0002A |
|
27 |
27 |
$936.45 |
| 0011A |
|
64 |
64 |
$757.60 |
| 20610 |
|
13 |
12 |
$681.04 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
30 |
12 |
$562.26 |
| 97032 |
|
38 |
13 |
$486.64 |
| 0031A |
|
13 |
12 |
$423.73 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
24 |
$363.58 |
| 90756 |
|
13 |
12 |
$150.24 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
63 |
61 |
$113.25 |
| 36415 |
Collection of venous blood by venipuncture |
593 |
560 |
$54.42 |
| 99490 |
Ccm add 20min |
14 |
13 |
$40.65 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
18 |
17 |
$30.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
72 |
69 |
$30.00 |
| 91301 |
|
111 |
98 |
$6.72 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
130 |
106 |
$1.72 |
| 91300 |
|
104 |
98 |
$1.60 |
| 1101F |
|
21 |
20 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
110 |
106 |
$0.00 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
90 |
86 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
37 |
36 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
22 |
21 |
$0.00 |
| 91303 |
|
13 |
12 |
$0.00 |
| 99406 |
|
17 |
17 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
17 |
16 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
16 |
16 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
19 |
18 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
48 |
46 |
$0.00 |
| 99497 |
|
13 |
13 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
18 |
18 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
23 |
22 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
54 |
52 |
$0.00 |
| 4004F |
|
16 |
16 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
25 |
24 |
$0.00 |